Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.29 trillion and total revenue of $109.89 billion.
Market Cap
1.29T
Revenue
109.89B
Profits
-41.36B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 134.02B | 6.03% | 1,864,703 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 66.56B | 4.73% | 1,071,132 | 14.92B |
| 3 | ARGX | argenx SE | 58.73B | 3.32% | 381,152 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.76B | 3.68% | 1,093,281 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.23B | 0.92% | 3,188,878 | - |
| 6 | RPRX | Royalty Pharma plc | 33.27B | 3.57% | 3,227,464 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 33.09B | 2.38% | 120,269 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 31.65B | 10.01% | 14,019,127 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.27B | 0.29% | 4,119,641 | 8.26M |
| 10 | BNTX | BioNTech SE | 24.67B | 3.86% | 1,390,437 | 3.23B |
| 11 | INSM | Insmed Incorporated | 24.19B | 4.30% | 2,396,352 | 819.56M |
| 12 | INCY | Incyte Corporation | 23.35B | 2.68% | 2,620,270 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.61B | 3.17% | 1,414,961 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 17.05B | 2.51% | 547,150 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.28B | 2.51% | 765,171 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.12B | 3.58% | 3,179,425 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 14.04B | 3.50% | 2,363,832 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.52B | 3.30% | 2,286,094 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.57B | 1.52% | 853,712 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.18B | 2.67% | 222,389 | 1.13B |
| 21 | SMMT | Summit Therapeutics Inc. | 11.97B | 7.23% | 7,095,977 | - |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.83B | 4.41% | 1,701,713 | 622.01M |
| 23 | CYTK | Cytokinetics, Incorporated | 11.74B | 1.44% | 2,022,480 | 105.82M |
| 24 | ABVX | ABIVAX Société Anonyme | 11.66B | 9.12% | 1,216,477 | 5.67M |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 11.40B | 2.02% | 1,481,631 | 3.24B |
| 26 | TECH | Bio-Techne Corporation | 11.06B | -0.24% | 7,812,863 | 1.21B |
| 27 | KRYS | Krystal Biotech, Inc. | 11.06B | 0.94% | 235,190 | 417.30M |
| 28 | APGE | Apogee Therapeutics, Inc. | 9.96B | 0.11% | 2,982,557 | - |
| 29 | IBRX | ImmunityBio, Inc. | 9.89B | 2.61% | 5,420,273 | 140.98M |
| 30 | NUVL | Nuvalent, Inc. | 9.77B | 0.11% | 1,283,536 | - |
| 31 | CORT | Corcept Therapeutics Incorporated | 9.68B | 1.96% | 771,933 | 769.10M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 9.42B | 3.17% | 1,558,182 | 1.51B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 9.33B | -0.72% | 788,282 | 51.48M |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.87B | -0.48% | 349,252 | 7.46M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.46B | 5.15% | 708,388 | 74.06M |
| 36 | PCVX | Vaxcyte, Inc. | 8.43B | 4.12% | 1,713,683 | - |
| 37 | IMVT | Immunovant, Inc. | 7.96B | 1.70% | 1,048,551 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.82B | 3.41% | 960,020 | 217.17M |
| 39 | SYRE | Spyre Therapeutics, Inc. | 7.72B | -2.54% | 973,913 | - |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 7.66B | 4.26% | 565,400 | 569.61M |
| 41 | TGTX | TG Therapeutics, Inc. | 7.56B | -0.39% | 3,042,410 | 700.35M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.91B | 2.41% | 6,748,273 | 827.11M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.61B | 0.55% | 1,602,464 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.58B | 3.86% | 1,726,048 | - |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.32B | 2.28% | 368,155 | 274.48M |
| 46 | CGON | CG Oncology, Inc. | 6.21B | -0.75% | 792,245 | 5.07M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.89B | 1.09% | 1,247,377 | 7.50M |
| 48 | DFTX | Definium Therapeutics, Inc. | 5.87B | 1.82% | 2,361,764 | - |
| 49 | CRSP | CRISPR Therapeutics AG | 5.79B | 8.02% | 2,925,035 | 4.10M |
| 50 | LEGN | Legend Biotech Corporation | 5.79B | 0.07% | 1,407,015 | 1.14B |
| 51 | BLTE | Belite Bio, Inc | 5.77B | 3.04% | 107,958 | - |
| 52 | ERAS | Erasca, Inc. | 5.74B | 3.07% | 4,095,201 | - |
| 53 | MANE | Veradermics, Incorporated | 5.42B | 0.98% | 562,996 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.29B | 1.03% | 1,472,335 | 536.20M |
| 55 | CELC | Celcuity Inc. | 5.26B | 3.31% | 906,231 | - |
| 56 | CAI | Caris Life Sciences, Inc. | 5.17B | -2.40% | 2,824,215 | 907.29M |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 5.16B | 4.63% | 753,164 | 1.34M |
| 58 | ORKA | Oruka Therapeutics, Inc. | 5.14B | -8.66% | 4,314,429 | - |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.45B | 9.18% | 2,176,658 | 18.07M |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | 3.06% | 1,549,042 | 1.10B |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.35B | -0.11% | 2,486,010 | - |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.26B | 2.54% | 2,307,381 | 56.99M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | 1.05% | 667,839 | - |
| 64 | DNLI | Denali Therapeutics Inc. | 4.10B | -0.58% | 1,541,124 | - |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 4.07B | -0.97% | 1,202,489 | 22.57M |
| 66 | RLAY | Relay Therapeutics, Inc. | 4.06B | 5.01% | 3,172,833 | 10.68M |
| 67 | TLX | Telix Pharmaceuticals Limited | 4.04B | 0.25% | 252,983 | 803.79M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 1,612,035 | 596.96M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.81B | 4.88% | 1,325,763 | 236.00M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.81B | 5.87% | 2,164,719 | - |
| 71 | GPCR | Structure Therapeutics Inc. | 3.80B | 2.55% | 590,515 | - |
| 72 | PBLS | Parabilis Medicines, Inc. | 3.77B | 6.56% | 302,372 | - |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.58B | 4.09% | 604,156 | 225.27M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.48B | 2.17% | 303,115 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 3.46B | 3.91% | 2,315,297 | 164.01M |
| 76 | ALMS | Alumis Inc. | 3.38B | -0.53% | 896,205 | 8.40M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.29B | 3.37% | 962,689 | 670.00M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -0.12% | 464,821 | 415.62M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.01B | 4.32% | 1,037,218 | 865.00K |
| 80 | VERA | Vera Therapeutics, Inc. | 2.96B | -3.42% | 5,016,651 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.91B | 1.75% | 985,673 | - |
| 82 | QURE | uniQure N.V. | 2.87B | -7.44% | 2,634,284 | 18.09M |
| 83 | KLRA | Kailera Therapeutics, Inc. | 2.85B | 5.62% | 392,305 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.82B | 7.47% | 1,783,219 | 535.08M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.79B | 12.89% | 4,235,360 | - |
| 86 | MBX | MBX Biosciences, Inc. | 2.75B | 3.36% | 828,662 | - |
| 87 | IMNM | Immunome, Inc. | 2.67B | 9.87% | 1,636,101 | 4.02M |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.55B | 1.82% | 2,202,177 | - |
| 89 | NRIX | Nurix Therapeutics, Inc. | 2.48B | 0.25% | 1,340,160 | 71.78M |
| 90 | ABCL | AbCellera Biologics Inc. | 2.48B | 6.71% | 8,442,107 | 79.21M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | 2.98% | 700,756 | - |
| 92 | NTLA | Intellia Therapeutics, Inc. | 2.41B | 1.86% | 4,160,317 | 66.09M |
| 93 | KOD | Kodiak Sciences Inc. | 2.41B | 3.49% | 1,005,980 | - |
| 94 | BHVN | Biohaven Ltd. | 2.40B | 1.27% | 3,530,586 | - |
| 95 | NKTR | Nektar Therapeutics | 2.40B | 10.33% | 998,921 | 55.63M |
| 96 | VCEL | Vericel Corporation | 2.40B | 4.05% | 640,667 | 292.09M |
| 97 | PHVS | Pharvaris N.V. | 2.37B | -0.27% | 478,098 | - |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.24B | 1.38% | 791,098 | 66.05M |
| 99 | GENB | Generate Biomedicines, Inc. | 2.23B | 5.52% | 759,759 | 30.30M |
| 100 | KARD | Kardigan, Inc. | 2.17B | 0.91% | 342,562 | - |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | 3.50% | 1,012,967 | 899.11M |
| 102 | ZLAB | Zai Lab Limited | 2.15B | -0.16% | 389,048 | 453.28M |
| 103 | VRDN | Viridian Therapeutics, Inc. | 2.14B | 4.98% | 1,949,433 | 70.92M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 2.11B | 1.80% | 1,832,276 | 52.04M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.10B | 5.85% | 321,848 | - |
| 106 | TSHA | Taysha Gene Therapies, Inc. | 2.09B | -1.80% | 2,278,183 | 7.47M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.07B | 3.95% | 2,034,228 | 509.86M |
| 108 | GLUE | Monte Rosa Therapeutics, Inc. | 2.05B | 0.79% | 548,113 | 42.95M |
| 109 | STOK | Stoke Therapeutics, Inc. | 2.04B | -0.03% | 1,009,125 | 32.08M |
| 110 | PGEN | Precigen, Inc. | 2.01B | 7.43% | 1,994,773 | 31.60M |
| 111 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -1.20% | 2,639,200 | 298.30M |
| 112 | LKFT | Lakefront Biotherapeutics NV | 1.99B | 2.67% | 159,237 | 1.20B |
| 113 | SION | Sionna Therapeutics, Inc. | 1.99B | 5.64% | 328,676 | - |
| 114 | NUVB | Nuvation Bio Inc. | 1.98B | 5.17% | 6,327,207 | 143.05M |
| 115 | ABSI | Absci Corporation | 1.97B | 4.59% | 5,260,638 | 1.84M |
| 116 | NBTX | Nanobiotix S.A. | 1.95B | -2.28% | 94,514 | 38.27M |
| 117 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | 3.54% | 31,404,120 | 66.41M |
| 118 | SNDX | Syndax Pharmaceuticals, Inc. | 1.93B | 4.45% | 2,197,351 | 217.17M |
| 119 | IOVA | Iovance Biotherapeutics, Inc. | 1.92B | 8.56% | 10,999,354 | 285.61M |
| 120 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 5.93% | 4,785,514 | 2.18B |
| 121 | ZYME | Zymeworks Inc. | 1.92B | 2.18% | 538,212 | 81.26M |
| 122 | ATAI | AtaiBeckley Inc. | 1.91B | 6.35% | 10,808,284 | 3.49M |
| 123 | BCAX | Bicara Therapeutics Inc. | 1.91B | 0.31% | 924,138 | - |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.86B | -1.07% | 254,369 | 20.00M |
| 125 | GHRS | GH Research PLC | 1.85B | 2.23% | 168,283 | - |
| 126 | URGN | UroGen Pharma Ltd. | 1.85B | 0.21% | 816,832 | 140.49M |
| 127 | ANAB | AnaptysBio, Inc. | 1.85B | -3.01% | 1,355,570 | 232.39M |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.85B | 10.67% | 760,856 | - |
| 129 | MESO | Mesoblast Limited | 1.84B | 2.06% | 191,681 | 65.38M |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.82B | 4.11% | 645,962 | - |
| 131 | AKTS | Aktis Oncology, Inc. | 1.76B | 2.95% | 723,630 | 8.28M |
| 132 | MAZE | Maze Therapeutics, Inc. | 1.73B | 4.86% | 575,497 | 20.00M |
| 133 | ZBIO | Zenas BioPharma, Inc. | 1.72B | -2.75% | 1,383,395 | 10.00M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.69B | 5.02% | 1,159,872 | 65.50M |
| 135 | MPLT | MapLight Therapeutics, Inc. | 1.68B | 2.80% | 367,146 | - |
| 136 | IMCR | Immunocore Holdings plc | 1.65B | 2.65% | 954,707 | 412.81M |
| 137 | INVA | Innoviva, Inc. | 1.65B | 1.87% | 655,045 | 420.69M |
| 138 | AAPG | Ascentage Pharma Group International | 1.64B | 1.28% | 13,518 | 82.08M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.63B | -1.71% | 1,371,980 | 2.71B |
| 140 | AVBP | ArriVent BioPharma, Inc. | 1.61B | 0.49% | 515,615 | - |
| 141 | NVAX | Novavax, Inc. | 1.60B | 2.96% | 4,846,215 | 596.34M |
| 142 | SVRA | Savara Inc. | 1.58B | 2.64% | 1,531,756 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.57B | -0.94% | 1,391,543 | - |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | -1.79% | 1,720,726 | 204.73M |
| 145 | SEPN | Septerna, Inc. | 1.53B | -1.76% | 475,768 | 72.26M |
| 146 | COAG | Hemab Therapeutics Holdings, Inc. | 1.44B | -5.14% | 240,589 | - |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.43B | 2.78% | 215,098 | 1.30M |
| 148 | IMTX | Immatics N.V. | 1.36B | 0.91% | 377,395 | 43.00M |
| 149 | CAPR | Capricor Therapeutics, Inc. | 1.34B | 0.61% | 1,640,168 | 11.13M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.32B | -1.66% | 570,188 | - |
| 151 | ARDX | Ardelyx, Inc. | 1.30B | 2.13% | 2,599,095 | 427.68M |
| 152 | MGTX | MeiraGTx Holdings plc | 1.29B | 8.75% | 521,115 | 79.76M |
| 153 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 3.18% | 1,317,863 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 1.28B | -1.38% | 1,204,531 | - |
| 155 | MNKD | MannKind Corporation | 1.25B | 11.60% | 3,985,061 | 360.78M |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | 6.89% | 2,174,012 | - |
| 157 | WVE | Wave Life Sciences Ltd. | 1.20B | 7.19% | 4,328,237 | 71.80M |
| 158 | SANA | Sana Biotechnology, Inc. | 1.20B | 12.64% | 5,251,055 | - |
| 159 | DRTS | Alpha Tau Medical Ltd. | 1.19B | 4.67% | 1,150,491 | - |
| 160 | EYPT | EyePoint, Inc. | 1.17B | 5.95% | 1,490,930 | 7.61M |
| 161 | VOR | Vor Biopharma Inc. | 1.12B | 11.96% | 3,910,213 | - |
| 162 | XNCR | Xencor, Inc. | 1.11B | -2.47% | 919,419 | 97.36M |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 1.10B | 4.64% | 1,375,875 | - |
| 164 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -4.10% | 220,743 | - |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 2.03% | 1,074,820 | - |
| 166 | SLDB | Solid Biosciences Inc. | 1.07B | 6.27% | 2,631,910 | - |
| 167 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.85% | 2,627,378 | 69.64M |
| 168 | AVTX | Avalo Therapeutics, Inc. | 990.34M | 8.96% | 1,815,832 | 59.00K |
| 169 | KURA | Kura Oncology, Inc. | 985.40M | 2.97% | 1,582,098 | 71.64M |
| 170 | PHAR | Pharming Group N.V. | 984.45M | 0.84% | 4,229 | 369.49M |
| 171 | DSGN | Design Therapeutics, Inc. | 976.83M | 6.68% | 1,578,324 | - |
| 172 | REPL | Replimune Group, Inc. | 972.08M | 3.21% | 1,294,041 | - |
| 173 | SLBT | SL Science Holding Limited | 968.13M | 34.61% | 1,123,442 | - |
| 174 | ABUS | Arbutus Biopharma Corporation | 962.01M | 2.96% | 2,601,251 | 191.45M |
| 175 | LBRX | LB Pharmaceuticals Inc | 958.66M | 4.83% | 406,031 | - |
| 176 | DBVT | DBV Technologies S.A. | 951.61M | 0.57% | 195,922 | 5.74M |
| 177 | JANX | Janux Therapeutics, Inc. | 948.92M | 6.14% | 1,037,680 | 13.73M |
| 178 | ANNX | Annexon, Inc. | 894.58M | -1.62% | 2,561,836 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 889.62M | 6.31% | 889,100 | 204.89M |
| 180 | IVA | Inventiva S.A. | 885.58M | 5.96% | 1,830,204 | 7.94M |
| 181 | TBPH | Theravance Biopharma, Inc. | 872.79M | -0.29% | 1,610,308 | 109.78M |
| 182 | GERN | Geron Corporation | 872.47M | 7.09% | 4,498,495 | 196.12M |
| 183 | ANRO | Alto Neuroscience, Inc. | 869.63M | -0.64% | 438,524 | - |
| 184 | AURA | Aura Biosciences, Inc. | 853.72M | 15.01% | 959,095 | - |
| 185 | OCS | Oculis Holding AG | 852.68M | 4.36% | 398,009 | 1.40M |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | 7.81% | 1,795,881 | 98.99M |
| 187 | CTMX | CytomX Therapeutics, Inc. | 831.63M | 6.11% | 5,122,998 | 35.54M |
| 188 | ZVRA | Zevra Therapeutics, Inc. | 826.43M | 1.23% | 1,146,649 | 122.29M |
| 189 | ODTX | Odyssey Therapeutics, Inc. | 801.48M | 0.78% | 206,823 | 1.06M |
| 190 | TENX | Tenax Therapeutics, Inc. | 789.88M | 16.33% | 3,720,319 | - |
| 191 | ACRS | Aclaris Therapeutics, Inc. | 776.53M | 4.12% | 1,942,405 | 8.37M |
| 192 | CLYM | Climb Bio, Inc. | 738.37M | -2.97% | 1,176,673 | - |
| 193 | IMMX | Immix Biopharma, Inc. | 736.10M | 5.19% | 2,074,479 | - |
| 194 | CADL | Candel Therapeutics, Inc. | 720.25M | -0.51% | 617,693 | - |
| 195 | ALLO | Allogene Therapeutics, Inc. | 717.92M | -1.42% | 4,280,986 | 22.00K |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 716.40M | 1.12% | 472,684 | 299.77M |
| 197 | TECX | Tectonic Therapeutic, Inc. | 715.71M | 15.85% | 478,325 | - |
| 198 | DRUG | Bright Minds Biosciences Inc. | 704.76M | 1.59% | 123,488 | - |
| 199 | PRME | Prime Medicine, Inc. | 698.99M | -0.51% | 5,601,037 | 4.03M |
| 200 | RGNX | REGENXBIO Inc. | 686.54M | 1.45% | 3,089,396 | 87.82M |
| 201 | CRMD | CorMedix Inc. | 686.45M | 3.31% | 1,043,607 | 400.05M |
| 202 | FDMT | 4D Molecular Therapeutics, Inc. | 679.59M | 2.44% | 1,002,630 | 88.24M |
| 203 | DNA | Ginkgo Bioworks Holdings, Inc. | 679.37M | 1.17% | 776,658 | 151.40M |
| 204 | EIKN | Eikon Therapeutics, Inc. | 678.90M | 2.37% | 457,406 | - |
| 205 | TRAX | First Tracks Biotherapeutics, Inc. | 673.42M | 3.82% | 558,172 | - |
| 206 | OMER | Omeros Corporation | 671.64M | -1.38% | 623,871 | 9.89M |
| 207 | GYRE | Gyre Therapeutics, Inc. | 669.76M | 12.42% | 101,710 | 117.05M |
| 208 | RLMD | Relmada Therapeutics, Inc. | 658.71M | -1.72% | 1,448,886 | - |
| 209 | ACHV | Achieve Life Sciences, Inc. | 657.02M | - | 1,712,856 | - |
| 210 | MNPR | Monopar Therapeutics Inc. | 655.07M | 2.90% | 188,240 | - |
| 211 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 649.67M | 3.97% | 401,380 | - |
| 212 | SGP | SpyGlass Pharma, Inc. | 635.23M | -2.41% | 120,708 | - |
| 213 | AGMB | AgomAb Therapeutics NV | 625.94M | 7.08% | 38,861 | - |
| 214 | ALT | Altimmune, Inc. | 614.54M | 0.32% | 4,041,662 | 36.00K |
| 215 | PROK | ProKidney Corp. | 613.18M | 7.41% | 1,597,041 | 889.00K |
| 216 | FTH | Faeth Therapeutics, Inc. | 590.85M | -3.13% | 185,854 | - |
| 217 | MDXG | MiMedx Group, Inc. | 588.34M | 1.28% | 662,464 | 389.42M |
| 218 | CBIO | Crescent Biopharma, Inc. | 567.88M | 0.06% | 265,925 | 11.88M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 564.53M | -0.92% | 378,660 | - |
| 220 | EDIT | Editas Medicine, Inc. | 560.14M | 11.28% | 4,023,059 | 38.69M |
| 221 | NGNE | Neurogene Inc. | 558.44M | 4.31% | 362,882 | 925.00K |
| 222 | ASMB | Assembly Biosciences, Inc. | 549.73M | 3.93% | 199,252 | 71.10M |
| 223 | STTK | Shattuck Labs, Inc. | 540.60M | 8.29% | 465,271 | 1.00M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 540.47M | 5.33% | 1,346,744 | - |
| 225 | XOMA | XOMA Royalty Corporation | 539.26M | 0.89% | 137,628 | 48.56M |
| 226 | ARVN | Arvinas, Inc. | 539.07M | 1.89% | 643,655 | 89.40M |
| 227 | CABA | Cabaletta Bio, Inc. | 520.14M | 6.69% | 8,256,527 | - |
| 228 | NVCT | Nuvectis Pharma, Inc. | 519.10M | 0.26% | 654,267 | - |
| 229 | RZLT | Rezolute, Inc. | 512.93M | -0.81% | 2,794,825 | - |
| 230 | OCGN | Ocugen, Inc. | 511.17M | 2.03% | 6,277,264 | 4.47M |
| 231 | FBRX | Forte Biosciences, Inc. | 509.48M | -2.20% | 401,427 | - |
| 232 | PRTA | Prothena Corporation plc | 507.83M | 1.25% | 462,875 | 57.94M |
| 233 | STRO | Sutro Biopharma, Inc. | 504.24M | 0.63% | 524,925 | 99.61M |
| 234 | OVID | Ovid Therapeutics Inc. | 502.06M | 0.37% | 1,886,942 | 7.12M |
| 235 | ZURA | Zura Bio Limited | 491.14M | 3.30% | 906,290 | - |
| 236 | SLN | Silence Therapeutics plc | 490.76M | -0.29% | 696,473 | 839.00K |
| 237 | VALN | Valneva SE | 487.25M | 2.65% | 19,019 | 180.25M |
| 238 | PRLD | Prelude Therapeutics Incorporated | 486.96M | - | 167,976 | 16.72M |
| 239 | CCCC | C4 Therapeutics, Inc. | 475.44M | -0.92% | 1,195,521 | 34.86M |
| 240 | SGMT | Sagimet Biosciences Inc. | 469.93M | 2.01% | 834,215 | - |
| 241 | ARTV | Artiva Biotherapeutics, Inc. | 466.93M | -1.94% | 435,838 | 251.00K |
| 242 | EVMN | Evommune, Inc. | 466.80M | 1.09% | 1,344,458 | 10.00M |
| 243 | BNTC | Benitec Biopharma Inc. | 453.99M | 4.14% | 172,366 | - |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 439.37M | 2.30% | 299,427 | 69.21M |
| 245 | IPSC | Century Therapeutics, Inc. | 438.26M | 1.67% | 839,712 | 109.16M |
| 246 | VTVT | vTv Therapeutics Inc. | 437.56M | 0.60% | 61,042 | 36.84M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 428.28M | -0.37% | 359,460 | - |
| 248 | AUTL | Autolus Therapeutics plc | 420.51M | - | 1,403,148 | 92.62M |
| 249 | PBYI | Puma Biotechnology, Inc. | 420.43M | 3.38% | 211,531 | 227.18M |
| 250 | RCKT | Rocket Pharmaceuticals, Inc. | 419.30M | 9.09% | 1,464,763 | - |
| 251 | DMAC | DiaMedica Therapeutics Inc. | 410.59M | 2.42% | 215,965 | - |
| 252 | CMPX | Compass Therapeutics, Inc. | 408.80M | 4.13% | 1,171,997 | 850.00K |
| 253 | UPB | Upstream Bio, Inc. | 408.69M | 3.16% | 363,212 | 3.32M |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 398.53M | 4.18% | 238,500 | - |
| 255 | VSTM | Verastem, Inc. | 395.43M | 9.76% | 2,967,535 | 49.59M |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 389.54M | 1.10% | 678,916 | 9.01M |
| 257 | HELP | Cybin Inc. | 386.78M | -0.64% | 897,779 | - |
| 258 | ANL | Adlai Nortye Ltd. | 379.60M | -10.47% | 358,569 | 5.00M |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 373.44M | 2.64% | 857,425 | 217.78M |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 371.69M | 3.48% | 139,357 | 51.00M |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 368.27M | 5.39% | 825,584 | - |
| 262 | ABEO | Abeona Therapeutics Inc. | 364.77M | 5.79% | 1,395,833 | 14.54M |
| 263 | PALI | Palisade Bio, Inc. | 364.52M | 6.60% | 3,347,835 | - |
| 264 | OABI | OmniAb, Inc. | 350.83M | 1.26% | 290,681 | 28.94M |
| 265 | IRD | Opus Genetics, Inc. | 344.30M | 1.20% | 847,547 | 11.98M |
| 266 | INDP | Indaptus Therapeutics, Inc. | 343.12M | 3.06% | 146,704 | - |
| 267 | FATE | Fate Therapeutics, Inc. | 340.35M | -3.31% | 4,192,199 | 6.32M |
| 268 | LRMR | Larimar Therapeutics, Inc. | 340.29M | 1.56% | 2,281,487 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 339.99M | 2.84% | 678,498 | 1.00 |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 336.55M | 3.85% | 723,972 | 14.78M |
| 271 | IMRX | Immuneering Corporation | 335.78M | 2.77% | 1,160,220 | - |
| 272 | IFRX | InflaRx N.V. | 329.94M | -3.86% | 777,375 | 33.82K |
| 273 | LYEL | Lyell Immunopharma, Inc. | 327.84M | 8.33% | 219,449 | 31.00K |
| 274 | GLSI | Greenwich LifeSciences, Inc. | 322.92M | -7.17% | 99,401 | - |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | 317.49M | 2.41% | 583,660 | 26.87M |
| 276 | FHTX | Foghorn Therapeutics Inc. | 311.18M | 5.79% | 380,057 | 28.22M |
| 277 | RNAC | Cartesian Therapeutics, Inc. | 311.15M | 4.03% | 177,998 | 1.78M |
| 278 | NMRA | Neumora Therapeutics, Inc. | 309.42M | 3.09% | 1,057,676 | - |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 305.34M | 1.28% | 1,164,922 | - |
| 280 | BCYC | Bicycle Therapeutics plc | 303.68M | 3.33% | 353,688 | 63.50M |
| 281 | MGNX | MacroGenics, Inc. | 299.38M | 1.95% | 860,646 | 157.08M |
| 282 | SABS | SAB Biotherapeutics, Inc. | 299.36M | 0.90% | 266,600 | 114.70K |
| 283 | GALT | Galectin Therapeutics Inc. | 297.01M | 4.16% | 722,831 | - |
| 284 | ADAG | Adagene Inc. | 294.02M | -6.90% | 81,652 | 7.67M |
| 285 | SRZN | Surrozen, Inc. | 289.33M | -2.35% | 99,788 | 7.49M |
| 286 | CNXU | Conexeu Sciences Inc. | 288.86M | 5.21% | 70,205 | - |
| 287 | TRDA | Entrada Therapeutics, Inc. | 278.18M | 1.71% | 360,864 | 5.74M |
| 288 | ALXO | ALX Oncology Holdings Inc. | 276.53M | -0.24% | 1,067,437 | - |
| 289 | NAGE | Niagen Bioscience, Inc. | 273.75M | 3.00% | 464,349 | 130.42M |
| 290 | IVVD | Invivyd, Inc. | 263.32M | 4.61% | 1,978,162 | 55.87M |
| 291 | FULC | Fulcrum Therapeutics, Inc. | 255.87M | 5.49% | 1,709,754 | 80.00M |
| 292 | AVXL | Anavex Life Sciences Corp. | 255.77M | 6.98% | 324,491 | - |
| 293 | PRQR | ProQR Therapeutics N.V. | 255.43M | 3.43% | 1,189,293 | 15.73M |
| 294 | OBIO | Orchestra BioMed Holdings, Inc. | 250.90M | -2.56% | 251,792 | 32.72M |
| 295 | ACIU | AC Immune SA | 248.99M | 5.46% | 364,528 | 4.62M |
| 296 | NBP | NovaBridge Biosciences | 247.49M | 7.54% | 462,999 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 241.94M | 2.81% | 28,667 | 18.47M |
| 298 | NERV | Minerva Neurosciences, Inc. | 237.60M | -0.97% | 286,901 | - |
| 299 | CLLS | Cellectis S.A. | 236.80M | 12.24% | 32,730 | 75.11M |
| 300 | RNA | Atrium Therapeutics, Inc. | 233.49M | 2.63% | 196,855 | 36.68M |
| 301 | NKTX | Nkarta, Inc. | 230.38M | 12.98% | 1,498,414 | - |
| 302 | CAMP | Camp4 Therapeutics Corporation | 230.03M | 2.07% | 73,996 | 3.93M |
| 303 | ALEC | Alector, Inc. | 228.71M | 2.49% | 393,984 | 18.42M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 228.39M | 5.00% | 1,119,168 | 36.49M |
| 305 | TARA | Protara Therapeutics, Inc. | 228.19M | 0.50% | 645,460 | - |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 225.35M | -2.56% | 322,070 | 7.15M |
| 307 | NGEN | NervGen Pharma Corp. | 225.15M | 1.44% | 601,069 | - |
| 308 | CDXS | Codexis, Inc. | 224.51M | 3.35% | 522,122 | 78.09M |
| 309 | CHRS | Coherus Oncology, Inc. | 224.43M | 1.04% | 850,846 | 46.88M |
| 310 | KROS | Keros Therapeutics, Inc. | 222.86M | 3.49% | 403,611 | 33.18M |
| 311 | QTTB | Q32 Bio Inc. | 221.96M | 3.89% | 162,604 | 53.74M |
| 312 | NAUT | Nautilus Biotechnology, Inc. | 219.85M | -5.98% | 782,798 | - |
| 313 | KPTI | Karyopharm Therapeutics Inc. | 217.11M | 0.31% | 317,737 | 151.12M |
| 314 | ARMP | Armata Pharmaceuticals, Inc. | 216.23M | 0.17% | 118,394 | 5.20M |
| 315 | CGEN | Compugen Ltd. | 215.65M | 7.04% | 261,261 | 72.66M |
| 316 | TTRX | Turn Therapeutics Inc. | 212.09M | 3.94% | 20,573 | - |
| 317 | DTIL | Precision BioSciences, Inc. | 211.06M | 3.81% | 600,930 | 45.07M |
| 318 | ARCT | Arcturus Therapeutics Holdings Inc. | 206.92M | 5.66% | 1,904,940 | 54.71M |
| 319 | KRRO | Korro Bio, Inc. | 201.92M | 2.56% | 324,589 | 3.84M |
| 320 | IMUX | Immunic, Inc. | 201.60M | -0.07% | 130,011 | - |
| 321 | CNTN | Canton Strategic Holdings, Inc. | 198.25M | -3.40% | 406,473 | - |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 197.54M | 5.79% | 350,576 | - |
| 323 | TNXP | Tonix Pharmaceuticals Holding Corp. | 196.71M | -0.80% | 326,445 | 17.56M |
| 324 | MDWD | MediWound Ltd. | 194.90M | 2.33% | 52,679 | 14.48M |
| 325 | HUMA | Humacyte, Inc. | 191.44M | 5.56% | 12,561,340 | 2.02M |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 188.26M | -0.22% | 360,791 | 2.00M |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 186.93M | 0.87% | 470,793 | 76.38M |
| 328 | OKUR | OnKure Therapeutics, Inc. | 185.82M | 3.14% | 222,298 | - |
| 329 | LENZ | LENZ Therapeutics, Inc. | 184.68M | 1.73% | 1,028,406 | 20.99M |
| 330 | EQ | Equillium, Inc. | 183.99M | -4.28% | 2,986,207 | 4.39M |
| 331 | CRBU | Caribou Biosciences, Inc. | 180.51M | 3.41% | 1,866,347 | 11.20M |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 179.59M | - | 1,047,254 | 1.78M |
| 333 | OTLK | Outlook Therapeutics, Inc. | 175.25M | -1.36% | 5,065,811 | 333.14K |
| 334 | ACOG | Alpha Cognition Inc. | 172.02M | 1.41% | 51,970 | 10.83M |
| 335 | IPHA | Innate Pharma S.A. | 171.81M | -0.28% | 5,969 | 10.57M |
| 336 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 171.38M | 1.98% | 444,849 | - |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 170.76M | 5.50% | 698,530 | 225.00K |
| 338 | TLSA | Tiziana Life Sciences Ltd | 169.39M | 6.50% | 161,179 | - |
| 339 | PYXS | Pyxis Oncology, Inc. | 166.62M | -7.72% | 693,015 | 13.86M |
| 340 | MENS | Jyong Biotech Ltd. | 164.80M | 8.29% | 207,454 | - |
| 341 | NRXP | NRx Pharmaceuticals, Inc. | 162.19M | 0.26% | 621,626 | 2.29M |
| 342 | ANTX | AN2 Therapeutics, Inc. | 159.19M | -5.96% | 143,766 | - |
| 343 | HURA | TuHURA Biosciences, Inc. | 155.39M | -0.41% | 363,223 | - |
| 344 | CNTB | Connect Biopharma Holdings Limited | 154.89M | 2.93% | 446,793 | 233.00K |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 152.99M | 8.52% | 2,988,986 | - |
| 346 | KZIA | Kazia Therapeutics Limited | 151.41M | -1.05% | 112,913 | 1.27M |
| 347 | ADCT | ADC Therapeutics SA | 151.36M | 4.39% | 1,803,107 | 79.18M |
| 348 | MOLN | Molecular Partners AG | 149.60M | 1.15% | 46,739 | 856.30K |
| 349 | AGEN | Agenus Inc. | 145.33M | 2.35% | 610,142 | 123.87M |
| 350 | SPRB | Spruce Biosciences, Inc. | 143.99M | -0.44% | 68,772 | 697.00K |
| 351 | COYA | Coya Therapeutics, Inc. | 137.46M | 3.53% | 107,477 | 7.94M |
| 352 | ALDX | Aldeyra Therapeutics, Inc. | 136.63M | -6.58% | 2,031,522 | - |
| 353 | YDES | YD Bio Limited | 133.61M | -17.75% | 345,087 | 510.36K |
| 354 | GNLX | Genelux Corporation | 133.23M | 3.45% | 195,980 | 8.00K |
| 355 | PLYX | Polaryx Therapeutics, Inc. | 133.03M | 8.91% | 36,911 | - |
| 356 | SPRO | Spero Therapeutics, Inc. | 127.38M | -0.90% | 629,507 | 61.19M |
| 357 | ENLV | Enlivex Ltd. | 127.18M | -2.58% | 568,921 | - |
| 358 | AARD | Aardvark Therapeutics, Inc. | 124.35M | 1.42% | 210,643 | - |
| 359 | PEPG | PepGen Inc. | 121.74M | -2.76% | 283,348 | - |
| 360 | GUTS | Fractyl Health, Inc. | 120.89M | -2.62% | 390,161 | 3.00K |
| 361 | ENGN | enGene Therapeutics Inc. | 119.91M | 1.14% | 588,284 | - |
| 362 | PMN | ProMIS Neurosciences, Inc. | 119.72M | -0.74% | 44,952 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 115.18M | 9.24% | 1,572,755 | 70.00M |
| 364 | CUE | Cue Biopharma, Inc. | 114.33M | -0.28% | 21,035 | 32.73M |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 113.01M | 4.86% | 56,292 | - |
| 366 | ANIX | Anixa Biosciences, Inc. | 111.26M | 4.14% | 134,010 | - |
| 367 | NTHI | NeOnc Technologies Holdings, Inc. | 109.37M | -3.14% | 90,144 | 39.99K |
| 368 | VANI | Vivani Medical, Inc. | 108.66M | 2.44% | 1,333,115 | - |
| 369 | ONCY | Oncolytics Biotech Inc. | 107.31M | -0.18% | 606,022 | - |
| 370 | CBUS | Cibus, Inc. | 105.72M | -2.46% | 105,504 | 4.29M |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 105.39M | 3.28% | 22,949 | 37.16M |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 104.97M | 2.46% | 30,052 | 23.14M |
| 373 | CGTX | Cognition Therapeutics, Inc. | 104.71M | 3.54% | 2,051,205 | - |
| 374 | BMEA | Biomea Fusion, Inc. | 101.94M | 3.68% | 452,676 | - |
| 375 | FBIO | Fortress Biotech, Inc. | 100.99M | -1.62% | 319,436 | 66.16M |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 100.37M | 2.52% | 2,757,429 | 65.34K |
| 377 | ATHE | Alterity Therapeutics Limited | 98.01M | -1.83% | 19,470 | 4.43M |
| 378 | ALPS | Alps Group Inc | 98.01M | 1.03% | 283,221 | 3.74M |
| 379 | PYPD | PolyPid Ltd. | 96.25M | -0.59% | 223,848 | - |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 95.39M | 0.21% | 504,189 | 3.17M |
| 381 | ACET | Adicet Bio, Inc. | 94.51M | 4.41% | 101,107 | - |
| 382 | ICCC | ImmuCell Corporation | 93.91M | -5.64% | 41,066 | 29.93M |
| 383 | RNTX | Rein Therapeutics Inc. | 92.25M | 1.38% | 142,251 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 89.57M | -7.96% | 27,661 | 27.70M |
| 385 | LIXT | Lixte Biotechnology Holdings, Inc. | 89.28M | -6.00% | 614,080 | - |
| 386 | SEER | Seer, Inc. | 89.07M | -0.61% | 6,444,720 | 15.17M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 88.16M | 1.40% | 444,123 | - |
| 388 | NRXS | NeurAxis, Inc. | 87.43M | -0.28% | 40,941 | 4.28M |
| 389 | TELO | Telomir Pharmaceuticals, Inc. | 87.34M | -2.31% | 46,998 | - |
| 390 | CRDF | Cardiff Oncology, Inc. | 86.83M | -1.55% | 734,094 | 525.00K |
| 391 | GOSS | Gossamer Bio, Inc. | 84.67M | 3.28% | 16,484,379 | 55.54M |
| 392 | OSTX | OS Therapies Incorporated | 84.18M | 4.42% | 622,945 | - |
| 393 | RLYB | Rallybio Corporation | 83.79M | -0.78% | 15,168 | 858.00K |
| 394 | IBIO | iBio, Inc. | 83.46M | -4.00% | 761,887 | 300.00K |
| 395 | ENTX | Entera Bio Ltd. | 83.19M | -1.78% | 126,525 | 42.00K |
| 396 | HRTX | Heron Therapeutics, Inc. | 82.98M | 3.30% | 3,064,578 | 150.71M |
| 397 | LONA | LeonaBio, Inc. | 82.66M | 5.01% | 22,855 | - |
| 398 | ANVS | Annovis Bio, Inc. | 82.11M | 0.52% | 958,292 | - |
| 399 | OKYO | OKYO Pharma Limited | 81.87M | 4.00% | 125,850 | - |
| 400 | GANX | Gain Therapeutics, Inc. | 81.47M | -4.02% | 378,468 | - |
| 401 | CSBR | Champions Oncology, Inc. | 79.99M | -4.71% | 1,532 | 57.95M |
| 402 | HYFT | MindWalk Holdings Corp. | 77.98M | -3.09% | 363,861 | 20.70M |
| 403 | BYSI | BeyondSpring Inc. | 76.89M | 1.08% | 36,151 | 1.88M |
| 404 | MCRB | Seres Therapeutics, Inc. | 74.95M | -2.52% | 129,372 | 1.15M |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 73.62M | -0.58% | 262,340 | - |
| 406 | CING | Cingulate Inc. | 72.46M | -8.66% | 375,309 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 71.29M | 4.51% | 702,109 | - |
| 408 | MNOV | MediciNova, Inc. | 70.39M | 0.70% | 14,218 | 596.64K |
| 409 | XBIT | XBiotech Inc. | 70.27M | 0.22% | 19,790 | - |
| 410 | TCRX | TScan Therapeutics, Inc. | 69.93M | - | 879,005 | 9.14M |
| 411 | EXOZ | eXoZymes, Inc. | 67.75M | -6.00% | 51,030 | -700.00 |
| 412 | EDSA | Edesa Biotech, Inc. | 66.69M | -3.23% | 68,020 | - |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 65.06M | -1.61% | 143,395 | - |
| 414 | IMA | ImageneBio, Inc. | 63.84M | -1.91% | 8,136 | 800.00K |
| 415 | ELTX | Elicio Therapeutics, Inc. | 61.41M | -37.35% | 4,335,712 | - |
| 416 | CNTX | Context Therapeutics Inc. | 60.06M | 7.46% | 1,240,925 | - |
| 417 | FLNA | Filana Therapeutics, Inc. | 59.42M | -1.60% | 637,062 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 58.14M | 1.83% | 6,808 | - |
| 419 | ATYR | aTyr Pharma, Inc. | 58.10M | 0.46% | 522,440 | 190.00K |
| 420 | IMMP | Immutep Limited | 56.95M | -2.20% | 386,618 | 5.28M |
| 421 | BOLD | Boundless Bio, Inc. | 56.16M | 0.81% | 139,278 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 54.32M | -1.52% | 16,425 | 53.48M |
| 423 | MREO | Mereo BioPharma Group plc | 53.42M | 3.62% | 863,167 | 500.00K |
| 424 | TIL | Instil Bio, Inc. | 52.42M | 0.52% | 6,841 | - |
| 425 | VRXA | Veraxa Biotech AG | 51.44M | 18.26% | 4,959,053 | - |
| 426 | RADX | Radiopharm Theranostics Limited | 51.36M | 2.82% | 18,037 | 10.86M |
| 427 | IBO | Impact BioMedical Inc. | 50.89M | -2.48% | 81,636 | 39.00K |
| 428 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.72M | 3.84% | 39,768 | - |
| 429 | LTRN | Lantern Pharma Inc. | 50.65M | -1.24% | 86,608 | - |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 50.11M | -0.67% | 106,597 | - |
| 431 | VERU | Veru Inc. | 49.11M | -3.16% | 262,028 | 16.89M |
| 432 | CRVO | CervoMed Inc. | 48.02M | -3.79% | 285,804 | 2.09M |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 47.44M | 4.13% | 355,824 | 22.33M |
| 434 | PDSB | PDS Biotechnology Corporation | 47.34M | -2.95% | 575,737 | - |
| 435 | HYPD | Hyperion DeFi, Inc. | 47.14M | -0.96% | 85,219 | 1.04M |
| 436 | ABVC | ABVC BioPharma, Inc. | 45.49M | 1.69% | 118,800 | 797.92K |
| 437 | INMB | INmune Bio Inc. | 45.19M | 1.19% | 340,809 | 50.00K |
| 438 | APLM | Apollomics, Inc. | 42.95M | -2.98% | 14,741 | 8.84M |
| 439 | ESLA | Estrella Immunopharma, Inc. | 42.60M | 0.76% | 18,399 | - |
| 440 | RNXT | RenovoRx, Inc. | 41.94M | -2.64% | 204,739 | 1.49M |
| 441 | GNTA | Genenta Science S.p.A. | 40.58M | -1.71% | 91,835 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 38.57M | 5.80% | 266,725 | - |
| 443 | NTRB | Nutriband Inc. | 37.20M | -0.97% | 3,934 | 1.80M |
| 444 | ACTU | Actuate Therapeutics, Inc. | 36.37M | 5.56% | 179,704 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 34.59M | 2.57% | 24,733 | 4.71M |
| 446 | DYAI | Dyadic International, Inc. | 34.27M | -7.79% | 97,324 | 3.81M |
| 447 | SNTI | Senti Biosciences Holdings, Inc. | 33.32M | 0.94% | 112,304 | 38.00K |
| 448 | LITS | Lite Strategy, Inc. | 32.31M | -2.08% | 189,466 | - |
| 449 | DARE | Daré Bioscience, Inc. | 31.31M | -0.95% | 122,391 | 1.16M |
| 450 | KYNB | Kyntra Bio, Inc. | 31.25M | 2.25% | 4,969 | 7.44M |
| 451 | KALA | KALA BIO, Inc. | 31.23M | -5.62% | 74,922 | - |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 30.78M | 0.12% | 32,842 | 90.00K |
| 453 | LSTA | Lisata Therapeutics, Inc. | 30.55M | -0.15% | 13,040 | 170.00K |
| 454 | NNVC | NanoViricides, Inc. | 30.30M | -1.48% | 89,205 | - |
| 455 | GRDX | GridAI Technologies Corp. | 29.67M | 0.22% | 42,196 | - |
| 456 | SER | Serina Therapeutics, Inc. | 28.50M | -1.04% | 19,038 | 130.00K |
| 457 | EVAX | Evaxion A/S | 28.44M | 6.56% | 20,766 | 7.53M |
| 458 | BCTX | BriaCell Therapeutics Corp. | 28.43M | -6.05% | 216,966 | - |
| 459 | IGC | IGC Pharma, Inc. | 28.12M | 2.26% | 411,958 | 1.11M |
| 460 | PSTV | Plus Therapeutics, Inc. | 27.39M | -4.33% | 223,131 | 5.18M |
| 461 | PLRZ | Polyrizon Ltd. | 25.83M | 8.83% | 117,126 | - |
| 462 | BRNS | Barinthus Biotherapeutics plc | 25.33M | -3.26% | 86,143 | 14.97M |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 25.03M | -2.07% | 231,750 | - |
| 464 | TVGN | Tevogen Bio Holdings Inc. | 24.62M | 2.44% | 12,892 | - |
| 465 | SKYE | Skye Bioscience, Inc. | 24.62M | 3.75% | 106,500 | - |
| 466 | MRKR | Marker Therapeutics, Inc. | 24.51M | 1.38% | 53,897 | 3.55M |
| 467 | QNTM | Quantum BioPharma Ltd. | 23.20M | 4.46% | 114,257 | - |
| 468 | PLUR | Pluri Inc. | 22.77M | 0.96% | 2,181 | 1.08M |
| 469 | VYNE | VYNE Therapeutics Inc. | 22.68M | -0.16% | 517,408 | 454.00K |
| 470 | CLRB | Cellectar Biosciences, Inc. | 22.46M | -0.71% | 26,215 | - |
| 471 | LGVN | Longeveron Inc. | 21.51M | -5.29% | 362,838 | 1.22M |
| 472 | ALLR | Allarity Therapeutics, Inc. | 20.84M | -1.50% | 116,439 | 345.00K |
| 473 | NCEL | NewcelX Ltd. | 20.73M | - | 37,402 | - |
| 474 | PTN | Palatin Technologies, Inc. | 20.66M | 12.20% | 25,551 | 12.88M |
| 475 | CVM | CEL-SCI Corporation | 19.92M | 8.57% | 248,620 | - |
| 476 | ICU | SeaStar Medical Holding Corporation | 19.78M | 1.23% | 279,138 | 1.44M |
| 477 | LPCN | Lipocine Inc. | 19.70M | -2.85% | 66,839 | 2.00M |
| 478 | TVRD | Tvardi Therapeutics, Inc. | 18.95M | 3.59% | 112,110 | - |
| 479 | AEON | AEON Biopharma, Inc. | 18.81M | 0.58% | 20,066 | - |
| 480 | KTTA | Pasithea Therapeutics Corp. | 18.37M | -3.02% | 415,090 | - |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 18.27M | -4.79% | 118,687 | -13.27K |
| 482 | ATOS | Atossa Therapeutics, Inc. | 18.26M | 3.92% | 116,461 | - |
| 483 | CELU | Celularity Inc. | 18.13M | 3.67% | 60,731 | 26.55M |
| 484 | GTBP | GT Biopharma, Inc. | 17.01M | -4.49% | 851,277 | - |
| 485 | QNCX | Quince Therapeutics, Inc. | 16.85M | 2.87% | 45,002 | - |
| 486 | MLEC | Moolec Science SA | 16.57M | 3.02% | 8,960 | 7.83M |
| 487 | HOWL | Werewolf Therapeutics, Inc. | 16.54M | -3.57% | 669,246 | 1.14M |
| 488 | CMMB | Chemomab Therapeutics Ltd. | 16.34M | 33.53% | 1,368,388 | - |
| 489 | HIND | Vyome Holdings, Inc. | 16.14M | 2.22% | 17,808 | 152.72K |
| 490 | TPST | Tempest Therapeutics, Inc. | 16.14M | -1.80% | 25,968 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 15.77M | -5.63% | 207,177 | 5.61M |
| 492 | CALC | CalciMedica, Inc. | 15.25M | -7.17% | 403,774 | - |
| 493 | PASG | Passage Bio, Inc. | 15.01M | 2.18% | 44,640 | - |
| 494 | BIVI | BioVie Inc. | 14.71M | -10.55% | 186,536 | - |
| 495 | LNAI | Lunai Bioworks Inc. | 14.51M | 3.56% | 58,902 | 20.94K |
| 496 | CYCN | Cyclerion Therapeutics, Inc. | 14.51M | 1.48% | 12,385 | 1.99M |
| 497 | COCP | Cocrystal Pharma, Inc. | 14.34M | -0.95% | 17,347 | 225.00K |
| 498 | MBRX | Moleculin Biotech, Inc. | 14.09M | -1.86% | 352,659 | - |
| 499 | INAB | IN8bio, Inc. | 13.98M | - | 18,939 | - |
| 500 | LEXX | Lexaria Bioscience Corp. | 13.88M | -2.08% | 7,671 | 368.00K |